Prevalence of gastrointestinal complications in patients with type 2 diabetes mellitus in Iran: a systematic review and meta-analysis

Kazeminia M 1 , Salari N 2 , Shohaimi S 3 , Akbari H 4 , Mohammadi M 4

Affiliations 

  • 1 Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • 2 Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • 3 Department of Biology, Faculty of Science, University Putra Malaysia, Serdang, Selangor Malaysia
  • 4 Cellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran
J Diabetes Metab Disord, 2022 Jun;21(1):1029-1036.
PMID: 35673410 DOI: 10.1007/s40200-022-00974-9

Abstract

BACKGROUND: Type 2 diabetes is the most common diabetes in the world and constitutes a high percentage of diabetes cases. This study aims to determine the overall prevalence of gastrointestinal complaints in Iranian patients with type 2 diabetes.

METHODS: The articles were extracted based on entry and exit criteria by searching the Cochrane (Embase), ScienceDirect databases. Scopus PubMed; And Web of Science (WoS), based on PRISMA 2009. To evaluate the studies, a 22-item STROBE checklist was selected and related items were used.

RESULTS: The probability of publication bias in reporting the results was examined by the Egger test (P = 0.891). The prevalence rate of gastrointestinal complaints in patients with type 2 diabetes in Iran in 10 studies was 52.3% (95% CI: 33.4-70.7%). The results of metargression showed a significant difference between the sample size and the prevalence of gastrointestinal complaints in patients with type 2 diabetes (P 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications